Synthesis and characterization of [125I]3'-(-)-iodopentazocine, a selective σ1 receptor ligand

European Journal of Pharmacology

Volumn 321, Issue 3, 1997, Pages 361-368

  Chien, Chih Cheng ^a,b   Carroll, F Ivy ^c   Brown, George P ^a   Pan, Ying Xin ^a   Bowen, Wayne ^d   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c RTI INTERNATIONAL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Receptor; Affinity label; Benzomorphane

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; IODINE 125; OPIATE; PENTAZOCINE; RECEPTOR SUBTYPE; SIGMA OPIATE RECEPTOR; 3' IODOPENTAZOCINE; 3'-IODOPENTAZOCINE; DRUG DERIVATIVE; LIGAND; RADIOACTIVE IODINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENANTIOMER; ISOTOPE LABELING; LIVER MEMBRANE; MEMBRANE BINDING; NEUROBLASTOMA CELL; NONHUMAN; PHOTOAFFINITY LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY; ULTRAVIOLET RADIATION; AFFINITY LABELING; ANIMAL; CELL LINE; CELL MEMBRANE; CHEMISTRY; COMPARATIVE STUDY; LIVER; METABOLISM;

AFFINITY LABELS; ANIMALS; CELL LINE; CELL MEMBRANE; IODINE RADIOISOTOPES; LIGANDS; LIVER; PENTAZOCINE; RATS; RECEPTORS, SIGMA;

EID: 0030610291     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00963-6     Document Type: Article

References (56)

1. Bastianetto, S., G. Perrault and D.J. Sanger, 1995, Pharmacological evidence for the involvement of sigma sites in DTG-induced contralateral circling in rats, Neuropharmacology 34, 107.
2. Bowen, W.D., S.B. Hellewell and K.A. McGarry, 1989, Evidence for a multi-site model of the rat brain sigma receptor, Eur. J. Pharmacol. 163, 309.
3. 3H](+)-pentazocine, a highly selective sigma ligand, Prog. Clin. Biol. Res. 328, 117.
4. Bowen, W.D., J.M. Walker, B.R. De Costa, R. Wu, P.J. Tolentino, D. Finn and K.C. Rice, 1992, Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors, J. Pharmacol. Exp. Ther. 262, 32.
5. 3H](+)-Pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors, Mol. Pharmacol. 3, 117.
6. Carr, D.J., S. Mayo, T.W. Woolley and B.R. DeCosta, 1992, Immunoregulatory properties of (+)-pentazocine and sigma ligands, Immunology 77, 527.
7. Chavkin, C. 1990, The sigma enigma: biochemical and functional correlates emerge for the haloperidol-sensitive sigma binding site, Trends Pharmacol. Sci. 11, 213.
8. 1 system, Eur. J. Pharmacol. 250, R7.
9. Chien, C.C. and G.W. Pasternak, 1994, Selective antagonism of opioid analgesia by a sigma system, J. Pharmacol. Exp. Ther. 271, 1583.
10. Chien, C.C. and G.W. Pasternak, 1995a, Sigma antagonists potentiate opioid analgesia in rats, Neurosci. Lett. 190, 137.
11. Chien, C.C. and G.W. Pasternak, 1995b, (-)-Pentazocine analgesia in mice: interactions with a σ receptor system, Eur. J. Pharmacol. 294, 303.
12. Ciccarone, V., B.A. Spengler, M.B. Myers, J.L. Biedler and R.A. Ross, 1989, Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages, Cancer Res. 49, 219.
13. 3 subtype, J. Pharmacol. Exp. Ther. 251, 461.
14. Danso-Danquah, R., X. Bai, X. Zhang, S.W. Mascarella, W. Williams, B. Sine, W.D. Bowen and F.I. Carroll, 1995, Synthesis and sigma binding properties of 1′- and 3′-halo- and 1′,3′-dihalo-N-normetazocine analogues, J. Med. Chem. 38, 2986.
15. DeCoster, M.A., K.L. Klette, E.S. Knight and F.C. Tortella, 1995, Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures, Brain Res. 671, 45.
16. DeHaven-Hudkins, D.L., L.F. Lanyon, F.Y. Ford-Rice and M.A. Ator, 1994, Sigma recognition sites in brain and peripheral tissues. Characterization and effects of cytochrome P450 inhibitors, Biochem. Pharmacol. 47, 1231.
17. 2 binding sites in rat heart membrane preparations, Eur. J. Pharmacol. 209, 245.
18. 3H]dopamine release from rat striatal slices by sigma receptor ligands, J. Pharmacol. Exp. Ther. 271, 212.
19. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine, J. Neurosci. 6, 1757.
20. ++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons, J. Pharmacol. Exp. Ther. 275, 207.
21. Hellewell, S.B. and W.D. Bowen, 1990, A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain, Brain Res. 527, 244.
22. 2 receptors: characterization by ligand binding and photoaffinity labeling, Eur. J. Pharmacol. 268, 9.
23. Itzhak, Y. and I. Stein, 1991, Regulation of sigma receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple sigma binding sites, Brain Res. 566, 166.
24. Itzhak, Y., M. Ruhland and H. Krahling, 1990, Binding of umespirone to the sigma receptor: evidence for multiple affinity states, Neuropharmacology 29, 181.
25. Itzhak, Y., I. Stein, S.H. Zhang, C.O. Kassim and D. Cristante, 1991, Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes, J. Pharmacol. Exp. Ther. 257, 141.
26. 125I]N-(2-Piperidinylaminoethyl)4-iodobenzamide and related analogs as sigma receptor imaging agents: high affinity binding to human malignant melanoma and rat C6 glioma cell lines, J. Label. Compd. Radiopharm. 33, 242.
27. John, C.S., B.J. Vilner and W.D. Bowen, 1994b, Synthesis and characterization of [125I](N-benzylpiperidin-4-yl)4-iodobenzamide, 4-IBP, a new sigma receptor radiopharmaceutical: high affinity binding to MCF-7 breast tumor cells, J. Med. Chem. 37, 1737.
28. 125I)Iodoazidococaine, a photo-affinity label for the haloperidol-sensitive sigma receptor, Proc. Natl. Acad. Sci. USA 89, 1393.
29. 3H]phenyl)-3-(2-methyl[4,6-3H]phenyl)guanidine, Proc. Natl. Acad. Sci. USA 85, 2844.
30. 125I]-1-(p-iodophenyl)-3-1-adamantyl)guanidine, a ligand for sigma binding sites, J. Med. Chem. 35, 4683.
31. Kreeger, J.S., R.Y. Yukhananov and A.A. Larson, 1995, Altered N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine is mediated by sigma activity, Brain Res. 672, 83.
32. Liu, Y., B.B. Whitlock, J.A. Pultz and S.A. Wolfe Jr., 1995, Sigma-1 receptors modulate functional activity of rat splenocytes, J. Neuroimmunol. 59, 143.
33. Lowry, O.H., N.J. Rosebrough, A.L. Fair and R.J. Randall, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265.
34. Musacchio, J.M., 1990, The psychotomimetic effects of opiates and the sigma receptor, Neuropsychopharmacology 3, 191.
35. Musacchio, J.M., M. Klein and P.D. Canoll, 1989, Dextromethorphan and sigma ligands: common sites but diverse effects, Life Sci. 45, 1721.
36. Okuyama, S., S. Ogawa, A. Nakazato and K. Tomizawa, 1995, Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats, Neurosci. Lett. 189, 60.
37. Paul, I.A., A.S. Basile, E. Rojas, M.B. Youdim, B. De Costa, P. Skolnick and G.A. Kuijpers, 1993, Sigma receptors modulate nicotinic receptor function in adrenal chromaffin cells, FASEB J. 7, 1171.
38. Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, S.W. Tam and D.P. Taylor, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci. 13, 85.
39. 3H]desmethylimipramine binding in bovine adrenal medulla: interactions with sigma-and (or) phencyclidine- receptor ligands, Can. J. Physiol. Pharmacol. 70, 1508.
40. Roman, F., X. Pascaud, D. Vauche and J.L. Junien, 1988, Evidence for a non-opioid sigma binding site in the guinea-pig myenteric plexus, Life Sci. 42, 2217.
41. Roman, F., X. Pascaud, G. Chomette, L. Bueno and J.L. Junien, 1989, Autoradiographic localization of sigma opioid receptors in the gastro-intestinal tract of the guinea pig, Gastroenterology 97, 76.
42. Ross, S.B., 1991, Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450, Pharmacol. Toxicol. 68, 293.
43. 3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands, Mol. Pharmacol. 39, 222.
44. Schuster, D.I., F.J. Arnold and R.B. Murphy, 1995, Purification, pharmacological characterization and photoaffinity labeling of sigma receptors from rat and bovine brain, Brain Res. 670, 14.
45. Shibata, S., Y. Yamamoto and S. Watanabe, 1995, A role of sigma receptors on hypoxia/hypoglycemia-induced decrease in CA1 presynaptic fiber spikes in rat hippocampal slices, Brain Res. 670, 337.
46. 3 opioid receptors in BE(2)-C neuroblastoma cells, J. Pharmacol. Exp. Ther. 270, 1246.
47. Su, T.P. 1991, Sigma receptors. Putative links between nervous, endocrine and immune systems, Eur. J. Biochem. 200, 633.
48. Su, T.P. and X.Z. Wu, 1990, Guinea pig vas deferens contains sigma but not phencyclidine receptors, Neurosci. Lett. 108, 341.
49. Vilner, B.J., B.R. De Costa and W.D. Bowen, 1995a, Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability, J. Neurosci. 15, 117.
50. Vilner, B.J., C.S. John and W.D. Bowen, 1995b, Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines, Cancer Res. 55, 408.
51. Walker, J.M., W.D. Bowen, F.O. Walker, R.R. Matsumoto, B. De Costa and K.C. Rice, 1990, Sigma receptors: biology and function, Pharmacol. Rev. 42, 355.
52. 3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study, Brain Res. 581, 33.
53. Wu, X.Z., J.A. Bell, C.E. Spivak, E.D. London and T.P. Su, 1991, Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor, J. Pharmacol. Exp. Ther. 257, 351.
54. Yamamoto, H., T. Yamamoto, N. Sagi, V. Klenerova, K. Goji, N. Kawai, Baba, A.E. Takamori and T. Moroji, 1995, Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site, J. Neurosci. 15, 731.
55. Yoneda, M., J.L. Junien and Y. Tache, 1992, Central action of sigma receptor ligand, JO 1784, to suppress CRF-induced inhibition of gastric function in conscious rats, Eur. J. Pharmacol. 223, 197.
56. Zhou, G.Z. and J.M. Musacchio, 1991, Computer-assisted modeling of multiple dextromethorphan and sigma binding sites in guinea pig brain, Eur. J. Pharmacol. 206, 261.